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ABSTRACT 
 
 Onchocerciasis, or river blindness, has historically represented one of the 
significant neglected tropical diseases on the planet in terms of socio-economic 
impact.  The discovery that ivermectin was a safe and effective treatment for 
onchocerciasis, together with the decision of the manufacturer to donate the drug 
for the treatment of this disease became the basis for several large international 
programs to control and eventually eliminate the infection.  These programs have 
managed to virtually eliminate transmission of the parasite causing Onchocerca 
volvulus from many foci in Africa and the Americas.  Verifying that transmission 
has been halted requires sensitive and specific assays to detect the presence of 
the parasite.  The gold standard to accomplish this has been to employ a PCR 
assay targeting a specific repeated sequence family encoded in the genome of 
O. volvulus to screen for the presence of the parasite in pools of vector black 
flies.  While this assay is highly sensitive, obtaining the high specificity required 
to document an absence of transmission requires an independent confirmatory 
assay.  To meet this need, an independent PCR assay targeting the cytochrome 
B (cytB) gene of the O. volvulus mitochondrion was developed.  This assay could 
detect O. volvulus mitochondrial DNA purified by magnetic bead capture using 
the primers for the cytB gene and from the nuclear encoded repeated sequence 
DNA targeted in the primary assay.  These preliminary data suggest that the 
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mitochondrial PCR assay may be employed as a confirmatory assay to detect O. 
volvulus in pools of vector flies.
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Chapter One:  Introduction 
 Onchocerciasis, caused by infection with Onchocerca volvulus, is one of 
the most significant neglected tropical diseases in the world, and historically was 
the second leading cause of infectious blindness, after trachoma.   O. volvulus is 
a nematode parasite and a member of a genus of tissue-dwelling filariae, 
Simulium.  Onchocerciasis is referred to as “river blindness” because the fly that 
transmits the disease flourishes and breeds near fast flowing rivers and streams.  
The long-standing, intense infection can lead to blindness that can cause loss of 
productivity in the affected areas.  There has been reduced economic 
productivity and an immense amount of abandoned, uninhabited land due to the 
fear of infection near these locations (OEPA, 2008).  Onchocerciasis has been 
found to have an effect on the quality of life and has also been reported to 
shorten the average lifespan of an adult.  Research has shown a positive 
association between O. volvulus microfilarial load and all-cause mortality (Udall, 
2007). 
 Onchocerca volvulus is estimated to have infected over 37 million people 
and currently over 90 million people live in areas that put them at risk.   Nearly 
270,000 have progressed to blindness because of infection with this parasite and 
500,000 have suffered from secondary visual impairment.  Worldwide, 
Onchocerciasis affects 34 countries in Africa, the Middle East, South America, 
and Central America (Udall 2007).  Onchocerca volvulus is endemic across the 
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entire continent of Africa and into Southwest Asia, with several foci in Yemen, 
Oman, Ecuador, Venezuela, Columbia, Brazil, southern Mexico, and Guatemala 
(Udall, 2007). 
 Onchocerca volvulus is transmitted through repeated bites from the black 
fly and has a 5-stage lifecycle where humans are the sole definitive host and the 
blackfly is the intermediate host (Udall, 2007).  When the black fly bites a person 
with an existing infection, the microscopic larvae in the infected person’s skin 
(microfilariae) enter and infect the black fly.  Over two weeks, the microfilariae 
penetrate the fly’s gut and migrate to the thoracic muscles where they develop to 
an infectious stage, third-stage larvae [L3] (Udall, 2007).  The larvae find their 
way to the black fly’s head capsule and when the fly takes a blood meal, it then 
drops the infective larvae that penetrate the skin and infect the new host.  With 
O. volvulus, prolonged and repeated exposure to the parasite is needed for an 
intense infection in the human host (OEPA, 2008). 
 The adult female worms live coiled up in a fibrous capsule under the skin 
or in the intrermuscular and periarticular tissue.  The female nematodes 
permanently incarcerate themselves in the nodules where they are relatively 
protected from the human immune response while the male nematodes move 
freely throughout the skin and subcutaneous spaces (Udall, 2007).  The females 
live for nine to fourteen years and produce large numbers microfilariae (OEPA, 
2008).  These first stage larvae, microfilariae, migrate to the sub-epidermal layer 
of the skin where they can be ingested by the vectors. The microfilariae live from 
six to twenty-four months in the human host and when they die, they cause many 
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inflammatory responses (OEPA, 2008).   The most common clinical presentation 
of onchocerciasis is diffuse papular dermatitis with intense pruritis.  Other results 
from the dying larvae include blinding sclerosal opacification, skin rashes, 
lesions, nodules, intense itching, skin depigmentation, inflammation, and swelling 
lymph glands.  Lesions on the cornea can progress to permanent clouding and 
blindness, particularly in longstanding intense.  Retinal and retinoic acids 
accumulate in the tissues after the death of the larvae and are moderately 
involved in the skin and ocular symptoms (Udall, 2007).  Repeated infection can 
also cause inflammation of the optic nerve resulting in loss of the peripheral 
vision.  Infected people may present themselves as asymptomatic as many 
larvae can move through the body without provoking a response from the 
immune system.  
 Diagnosing onchocerciasis is difficult because it takes about a year and a 
half for the worms to mature and release enough microfilarae to be detectable.  
The gold standard for diagnosis is the skin snip microscopy and in this 
procedure, a biopsy of the skin is taken to microscopically identify larvae after the 
sample is submerged in saline and incubated.  If the results of the initial 
incubation are not conclusive, a polymerase chain reaction (PCR) may be utilized 
to amplify the results.  The skin snips are becoming increasingly more unpopular 
in areas where O. volvulus is endemic because it is less sensitive than newer 
methods of detection where there is a very low prevalence of cases.  Another 
method for diagnosing severe infection includes surgical removal and 
examination of a nodule, nodulectomy.  An angiogenic protein produced by adult 
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female filarae cause the subdermal nodules, onchocercomata.  In many places 
where S. ochraceum (black fly species) is the main vector, nodulectomy is used 
to reduce the incidence of severe eye lesions and blindness but it cannot 
significantly reduce transmission (OEPA, 2008).  Additionally, eye infections can 
be determined with a slit lamp examination of the front part of the eye where the 
larvae or lesions are visible.  Antibody based tests are also widely used because 
they are less expensive and field-friendly but they are not able to distinguish 
between current and past infections.  Research has shown that a serum antibody 
test card using recombinant antigens from a finger-prick blood specimen was 
successfully used to detect O. volvulus specific IgG4 (Weil, 2000).  Antigen 
detection dipstick assays are also shown to have promising findings (Golden, 
2013). 
Ivermectin is a dependable drug used for mass treatment of 
onchocerciasis.  This medication has greatly reduced onchocerciasis in more 
than 25 countries worldwide.  Ivermectin is a lipophilic, 16-membered 
macrocyclic lactone from Streptomyces avermitilis and is very effective in killing 
microfilaria (Udall, 2007).  It does this by blocking the postsynaptic, glutamate 
gated chloride ion channels, inhibiting transmission, and paralyzing the filarae.  
Ivermectin also sterilizes the adult females but does not have a macrofilaricidal 
effect on the nematodes (Cupp, 2011).  It must be given orally every six to twelve 
months for the life span of the adult worms or as long as the individual has signs 
of an infection.   This drug can also be associated with post treatment reactions 
such as edema, pruritus, and backache due to microfilariae death.  The great 
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success of programs utilizing ivermectin have shown that it is plausible to carry 
out considerable efforts against chronic diseases in many remote and poor 
locations to improve morbidity, productivity, and mortality (Cupp, 2011).  
 New advances in drug therapy show that the use of doxycycline may be 
an effective anti-helminthic.  Doxycycline has been shown to kill and sterilize the 
adult worms by killing the Wolbachia bacteria, an endosymbiotic rickettsia-like 
bacterium on which the adult worms feed in order to survive.  The Wolbachia 
bacteria, found in filarial nematodes, are very important for fecundity, existence, 
and filarial antioxidant protection (Unnasch, 2000).  They inhabit the endodermis 
of female O. volvulus nematodes and many stages of its intrauterine embryos 
(Udall, 2007).  Research has shown that doxycycline blocks embryogenesis for 
18 months after treatment and ivermectin controls against late-stage microfilaria 
in the uterus.  It is suggested that infected patients receive both treatments 
because ivermectin has little to no effect on the early stage embryos.  Both 
treatments should be made available for infected persons no longer in an 
endemic area to reach long-term amicrofilaridemia.  Doxycycline therapy should 
be delayed several days after administering ivermectin to prevent potential 
adverse drug interactions from occurring.   
Mass drug administration of Ivermectin on an annual or semi-annual basis 
is one way to implement a large-scale control program for Onchocerciasis.  This 
intervention is aimed at the community level but it does not account for the 
problem of reinfection.  Without being able to control the vector, reemergence of 
the parasite will occur which will lead to repeated rounds of treatment (Prichard, 
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2012).  Some research has suggested that emerging drug resistance is occurring 
in O. volvulus with prolonged mass drug administration of ivermectin.  This 
resistance is described as a suboptimal response to ivermectin, defined as “a 
higher than normal rate of skin repopulation by O. volvulus microfilariae” (Cupp, 
2011).  However, additional research has shown contraindicating evidence to the 
theory of resistance suggesting that the repopulation of the skin was caused by 
the failure to achieve adequate drug coverage or from the young, fertile worms 
recovering rapidly from treatment.  The absence of widespread coverage is the 
most probable cause of the suboptimal responses and not a biochemical-based 
resistance.  The killing of the microfilariae by the immune system may also play a 
role in the suboptimal responses.  The absence of a laboratory host for O. 
volvulus and the lack of tools to mange the parasite have made it close to 
impossible to conduct a study to associate specific parasite genotypes with 
resistance directly (Cupp, 2011).  There has been no direct proof that resistance 
of ivermectin to O. volvulus has occurred and any research suggesting otherwise 
has been indirect, inferential, or correlative.  Elimination of the parasite is our 
best means to keep the disease Onchocerciasis at bay.  Detection and treatment 
are important features in controlling O. volvulus but monitoring and surveillance 
should also be implemented.  
There are also some contraindications for the medications.  A 
considerable peripheral problem involving the use of ivermectin for 
onchocerciasis control is the association of fatal encephalitic reactions believed 
to be induced by the killing of Loa loa microfilariae in people having dual 
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infections.  Children under 12 and pregnant or lactating women should also 
refrain from this treatment.  Such undesirable outcomes limit the distribution of 
ivermectin in hypo-endemic areas where onchocerciasis is persisting because 
the risk of treatment outweighs the benefits (Cupp, 2011).  This also contributes 
to the ivermectin coverage problems.  In many communities around the world 
where ivermectin was distributed annually, the prevalence of onchocerciasis was 
drastically diminished.  
 There are no vaccines or medications on the market currently that can 
completely prevent onchocerciasis.  Black flies bite during the day so personal 
protective measures such as wearing insect repellant on exposed skin, pants and 
long-sleeved shirts, and permethrin treated clothing are the best prevention.  
Onchocerciasis has also been widely controlled through spraying of black fly 
breeding sites with insecticide in endemic areas.   
Helminths have a unique evolutionary arrangement with the mammalian 
immune system and appear drastically different than those for protozoan, 
bacterial, and viral infections (Nutman, 2002).  Normal vaccine strategies are not 
applicable for these genetically diverse parasites, but should findings be 
achieved, they would most likely apply to all other filarial infections (Cook, 2001).  
The research world has limited access to this parasite because it can only be 
effectively sustained in chimpanzees.  They have proven to be useful models for 
pharmaceutical and pathological studies of ivermectin treatment on prepatent 
parasite development.  They have also been helpful in studying the immune 
responsiveness over the course of parasite development (Cupp, 2011).  Most 
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adult worms are obtained by surgically removing them from infected patients in 
Africa and the infective-stage larva is collected from the black flies feeding on 
infected humans (Cook, 2001).  O. volvulus is an obligate parasite in humans, 
however chimpanzees have been able to develop patent infections. 
As mentioned previously, antibody tests can be used to determine if there 
is exposure to the parasite.  Although these tests cannot distinguish between 
past and current infections, they are useful for visitors to endemic areas rather 
than for people that live there.  There is a general test for any filarial infection and 
also those specific to Onchocerciasis, such as the OV-16 antigen antibody test 
and the OV luciferase, but these are used mainly in the research setting.  These 
specific tests can also pick up signs of infection in the pre-patent stage.  In 2012, 
Standard Diagnostics and PATH announced their intent to manufacture and 
distribute a novel OV-16 rapid test that would be based on the detection of 
antibodies to the parasite antigen OV-16 (MacIver, 2012).  Scientists at the 
National Institute of Allergy and Infectious Diseases discovered the OV-16 
antigen, a recombinant antigen of O. volvulus.  There are many limitations of 
existing diagnostic tools in use today, so the OV-16 rapid test can be used as a 
form of support as the disease elimination phase closes in (MacIver, 2012).  The 
point-of-care rapid test can be used to monitor post control areas for signs of 
reinfection or detection of cases in typically low prevalence areas.  It can also 
help to exclude infection when the skin snips are negative (MacIver, 2012).  
When referring to the genome, one is usually indicating the nuclear 
genome.  Most eukaryotic organisms also contain a mitochondrial genome along 
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with the nuclear genome, as Onchocerca volvulus does.  O. volvulus also 
contains a third genome, a bacterial endosymbiont of the genus Wolbachia, that 
plays a role in the parasite fecundity.  The nuclear genome is predicted to be 
approximately 1.5 x 108 bp and the genes seem to be very compact, averaging 
about 5 kbp in size, distributed among four pairs of chromosomes. The nuclear 
genome of O. volvulus contains a large section of non-coding sequences, from 
which two families have been identified.  These were discovered from genetic 
screens to identify DNA probes that would be useful to identify the parasite.  One 
of the well-defined families in the nuclear genome is a tandemly repeated 
sequence with a length of 150 bp, known as the O-150 repeat family (Unnasch, 
2000). This represents about 1% of the total O. volvulus genome and is specific 
for parasites in the genus Onchocerca.  The mitochondrial genome is very 
compact with just 13,747 bp in size, making it the smallest metazoan 
mitochondrial genome (Unnasch, 2000).   
Currently, the accepted method for pool screening of the vector blackflies 
to detect the presence of O. volvulus relies on screening DNA prepared from fly 
pools with a PCR assay targeting a repeated sequence family in the parasite 
genome, the O-150 repeat (Meredith, 1991).  The infective stage of Onchocerca 
is the only stage found in fly head capsules, so the heads and bodies are 
separated to estimate the prevalence of infective black flies.  Using a PCR assay 
to monitor the transmission we are able to see, from the heads, which flies are 
infective and from the bodies, which have immature larval stages.  The infective 
rate (flies carrying infective larvae) is the proportion of flies infected based on the 
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heads and the infection rate (flies carrying any stage) is calculated from the 
proportion of flies infected based on the fly bodies (OEPA, 2008).  If elimination 
has been certified for a region, testing flies bodies for surveillance is an important 
measure because it can indicate vector contact with a microfilaria-positive person 
while testing the fly heads indicate which flies are currently infective.  The goal of 
the OEPA (Onchocerciasis Elimination for the Americas) is to eliminate new 
ocular morbidity caused by O. volvulus and to eliminate the transmission of the 
filarial parasite (Rodriguez-Perez, 2013).  The World Health Organization and 
OEPA have developed entomological and epidemiologic criteria currently being 
used by the OEPA to certify elimination (Rodriguez-Perez, 2013).  This 
certification is especially important in eliminating the parasite after treatment with 
ivermectin has been ceased because measuring the amount of infective stages 
of the parasite in the black fly population correlates to the measure of 
transmission in an area (Gopal, 2012).  To demonstrate that onchocerciasis 
transmission has been interrupted, a large number of flies are to be tested.  The 
OEPA guidelines require less than 1 out of every 2000 flies in every sentinel 
community be carrying infective larvae for transmission to be considered halted 
in the area (Lindblade, 2007).  In order to say with a 95% confidence interval that 
1 out of every 2000 flies is infective, a total number of 6000 flies are to be tested 
from every sentinel community (WHO, 2001).  In order to screen this large 
amount of flies for every sentinel community, the method of PCR pool screening 
is utilized to document transmission interruption.  This method of PCR pool 
screening is limited by the size of the pools of the vector blackflies that can be 
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screened.  The maximum number of flies the current PCR pool screening method 
can be applied to is 50 Latin American or 100 African black fly vectors.  
Previously, a PCR screening pool of 50 flies was widely accepted.  The new 
approach being tested is to detect one infective larva in a pool of 200 black flies 
by using streptavidin coated magnetic beads to isolate Onchocerca volvulus DNA 
from homogenates mixed with pools of vector black flies (Gopal, 2012).   
Determining the number of new infections and detecting possible renewal 
of parasite transmission within a low prevalence control area is very arduous 
because of the difficultly in detecting light infections and the relatively long 
prepatent period in human infection (Unnasch, 1987).  The prepatent period can 
be anywhere from ten to twenty-four months for the appearance of nodules or 
microfilarae in the skin to be detectable.  Infection rates in the black fly vectors 
are rapid and sensitive indicators of the constant change of microfilarial load in 
an area due to the use of ivermectin and theses changes in the infection rates 
correlate well with the percent of ivermectin coverage in the human population 
(OEPA, 2008).  Absence of the infective stage larvae (L3) in the black fly vector 
population during the transmission season is a very crucial indicator to show 
interruption of O. volvulus transmission.  Assays using DNA probes can rapidly 
detect infective larvae from Onchocerca volvulus within the black fly vectors 
populations and distinguish the larvae from those of related filaria, making this 
assay very specific.  Using O. volvulus specific DNA probes specificity is assured 
and this increases the reliability of the results and allows for large numbers of 
flies to be processed (OEPA, 2008).  The probe used in this assay is selective 
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enough to detect Onchocerca volvulus DNA in crude preparations containing 
DNA from the black fly vector.  Limits of detection assays were also conducted 
using ten fold dilutions of O. volvulus genomic DNA showing this assay very 
sensitive.  The absence, or near absence, of the infective-stage larvae of O. 
volvulus in the blackfly vector population will be determined by PCR using O. 
volvulus probes to certify that transmission has been interrupted.  Due to the 
potentially severe sequelae of Onchocerca volvulus infection previously 
discussed, it is important to achieve high values of positive predictive value when 
discussing the statistical measures of screening and testing methods.  The 
positive predictive value is a result that is both positive and correct when 
discussing evidence of active infection in a low prevalence region.  Maintaining a 
high positive predictive value requires the use of assays that are highly specific. 
PCR based assays targeting specific genomic sequences are theoretically 100% 
specific.  In practical terms, PCR assays are subject to false positive results that 
are caused by contamination with amplicons.  This obstacle can be overcome by 
employing a confirmatory assay that targets an independent portion of the target 
organism’s genome. The goal of this study was to develop a confirmatory assay 
to supplement the use of the O-150 PCR, increasing the specificity of the PCR 
for monitoring O. volvulus transmission in low intensity areas and for certifying 
elimination of the parasite. 
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Chapter Two:  Materials and Methods 
The materials and methods used for this experiment were Latin American 
black flies (Simulium ochraceum) and O. volvulus infective larvae (L3).  O. 
volvulus larvae were prepared under a microscope.  Each larva was identified 
and then separated in 100 µl of PBS buffer.   
Pools containing 200 flies each were prepared and the heads and bodies 
were separated using the following isolation procedures.  The flies preserved in 
95% ethanol were allowed to dry out until all of the ethanol had evaporated.  The 
flies were then placed in a clean 1.5 ml microfuge tube and put in the Tissue 
Lyser (Qiagen) shaker for 3 minutes at 30 Hz to snap the heads off of the bodies.  
They were then poured over a 25-mesh sieve connected to a pan to separate the 
heads from the bodies.  The bodies were collected on the sieve and the heads 
passed through the mesh.  Pools were made with 200 fly heads each.  In this 
study, four separate experiments were conducted which are described in further 
detail later. 
DNA Extractions 
In brief, the DNA extractions were performed by adjusting the volume in 
the microfuge tubes to 500 µl using TE80 (10 mM Tris-HCl (pH 8.0) 1 mM EDTA) 
and adding 50 µl 20 mg/ml proteinase K to each sample.  The homogenates 
were then incubated for 2 hours at 56°C.  Then, 10 µl of 1M DTT (dithiothreitol) 
was added and incubated for 30 minutes at 95°C for a final concentration of 20 
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mM.  The tube was subjected to three freeze-thaw cycles using a 15-minute 
freeze and a 10-minute thaw time.  The tube was then centrifuged for 5 minutes 
at 12000rmp and the supernatant removed and placed in a new tube containing 
the DNA.   
Magnetic Bead Capture 
The magnetic bead capture of DNA used in the experiments below were 
performed by adding 25 µl 2M Tris HCl (pH 7.5) 100mM and 12.5 µl 4M NaCl 
100mM to each sample.  Also added was a 1:1 mixture of 5 µl 0.5 µm 0150 
probe (OVS-2-biotin, B-5’AATCTCAAAAAACGGGTACATA-3’, where B=biotin) 
and 5 µl 0.5 µm OV mitochondrial 2353 probe (B-
5’GTTTTAGGCTATTGGGCTG-3’) and the samples were heated to 95°C for 
three minutes in the hot block and then allowed to cool to approximately 35°C to 
allow the probes to anneal to the DNA in the solution.  During that cooling time, 
the Dynal M-280 streptavidin magnetic beads (Invitrogen) were re-suspended by 
shaking and enough beads were removed so that each tube had at least 10 µl 
per sample.  The beads were then pipetted into a micro titer plate well and 
allowed them to collect on the magnet capture unit for 2 minutes.  After, the 
beads were washed five times with 200 µl of binding buffer and allowed to collect 
for two minutes between washes.  The beads were then re-suspended in the 
original volume of binding buffer (100mM Tris HCl (pH 7.5) 100 mM NaCl) and 10 
µl of the bead solution was added to each sample and incubated on a roller 
overnight at room temperature to allow the oligonucleotide-DNA hybrids to bind 
to the beads.  The next day, the samples are placed on the micro titer plate and 
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the beads are allowed to settle on the magnet for two minutes undisturbed and 
the supernatant was discarded.  The beads are then washed again six times 
using 150 µl of binding buffer per wash.  After the last wash, as much solution 
was removed as possible.  The beads are re-suspended in 20 µl of PCR sterile 
water and incubated for 2 minutes at 80°C in the hot block followed by a quick 
chill on ice.  The samples are then placed on the magnet and the beads allowed 
to collect again for another two minutes.  The supernatant containing the purified 
DNA was then removed to a new microfuge tube. 
The magnetic bead capture method was used in this experiment to isolate 
Onchocerca volvulus DNA from homogenates prepared from pools of vector 
black flies.  Throughout this process Streptavidin magnetic beads are used for 
the magnetic purification of the captured DNA complexes. 
 
 
Figure 1.1.  Dynabeads M-280 Streptavidin. 
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 Figure 1.1 shows the identification and purification of a sequence specific 
DNA.  The sample containing the DNA is first denatured at 95°C for 3 minutes.  
The biotinylated probes (0150 probe (OVS-2-biotin, B-
5’AATCTCAAAAAACGGGTACATA-3’, where B=biotin) and OV mitochondrial 
2353 probe (B-5’GTTTTAGGCTATTGGGCTG-3’)) were then attached to the 
target site.  To the mixture, streptavidin magnetic beads are added and allowed 
to bind to the biotin overnight at room temperature and adhere to the DNA. Using 
a magnetic capture unit, the beads were separated from the contaminants 
remaining in the solution and are then washed several times in purified water and 
analyzed by PCR.  
Protocol For Sequential Larvae Detection 
Limit of detection assays were initially carried out using ten fold dilutions of 
O. volvulus genomic DNA.  A total of 10 µl of dilutions of the purified genomic 
DNA was used as a template for the initial O-150 PCR amplifications performed 
in a total volume of 25 µl.  The reaction mixture contained 60 mM Tris-HCl (pH 
9), 15 mM (NH4)2SO4, 2 mM MgCl2, 200µM each of dATP, dCTP, dGTP, and 
dTTP, 0.5mM of each primer, and 2.5 units of Taq polymerase (Invitrogen).  The 
sequence of the primers used were (5’-GATTYTTCCGRCGAANARCGC-3’) and 
(5’-B-GCNRTRTAAATNTGNAAATTC-3’, where B=biotin).  The cycling 
conditions consisted of five cycles of one minute at 94°C, two minute at 37°C, 
and 30 seconds at 72°C.  This was followed by 35 cycles of 30 seconds at 94°C, 
30 seconds at 37°C, and 30 seconds at 72°C.  The PCR was completed with 6 
minutes at 72°C and was held continuously at 4°C. 
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An enzyme-linked immunosorbent assay was then used to detect the O-
150 amplicons.  In brief, U-bottom plates were coated with 100 µl of 1µg/ml 
Streptavidin in coating buffer (0.1 M carbonate-bicarbonate buffer, pH 9.6) 
overnight at 4°C and then washed six times with TBS/Tween (TRIS-buffered 
saline/0.05% Tween 20).  About 20 µl of hybridization buffer (6X sodium chloride, 
sodium phosphate, EDTA[SSPE]/5X Denhardt’s solution/0.1% sodium 
sarcosine/0.02%SDS) was added to each well along with 5 µl of undiluted PCR 
product to the appropriate wells.  The plate was then incubated for 30 minutes at 
room temperature and then washed six times with TBS/Tween.  Next, 100 µl 1 N 
NaOH was added to all the wells and incubated for one minute at room 
temperature to denature the plate-bound double-stranded PCR products.  The 
wash was repeated six times with TBS/Tween.  50 µl OVS2-FL probe diluted to 
50 ng/ml in hybridization buffer was then added to all the wells and the plate was 
incubated for 15 minutes at 42°C.  The wash was repeated six times with 
TBS/Tween and 100 µl of pre-warmed wash buffer (0.1 X SSPE/0.1% SDS pre-
warmed to 42°C) was added to all wells and the plate was incubated for 10 
minutes at 42°C.  The plate was washed again six times with TBS/Tween and 50 
µl of the diluted anti-florescin Fab fragment was added to each well.  The plate 
was incubated for 15 minutes at 37°C and washed again six times with 
TBS/Tween.  Then, 100 µl of freshly mixed BluePhos Microwell Phosphatase 
Substrate System (a soluble, proprietary form of 5-bromo-4chloro-3indolyl 
phosphate used with alkaline phosphatase-labeled antibodies) was added to 
each well and the plate was incubated at room temperature for 30 minutes.  The 
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blue color was allowed to develop for 30 minutes and then 100 µl of 1X APstop 
solution (ethylenediaminetetraacetic acid [EDTA] based solution formulated for 
stopping AP substrate color development) was added to each well.  The plate is 
then read at 630 nm on a microplate reader (GeneMate, UniRead 800).  The 
cutoff value was calculated from the result of 10 negative controls performed in 
parallel wells using the formula mean optical density plus three standard 
deviations.  A sample was considered positive when its OD value was greater 
than the cutoff value. 
For the purpose of this experiment, a PCR primer was developed that 
amplifies the 205nt (nucleotide) of the cytochrome B gene of O. volvulus.  Nested 
PCRs were then performed targeting a 97nt fragment internal to the 205nt 
fragment targeted in the initial assay.  Incorporating the nesting step into the 
protocol increased the biochemical sensitivity of the assay, lowering the limit of 
detection. 
To carry out this assay, 10 µl of the purified diluted genomic DNA samples 
described above were used as the template for the OV mitochondrial PCR 
amplifications, which targeted a 205nt fragment of the O. volvulus cytochrome B 
gene.  Performed in a total volume of 25 µl, the reaction mixture contained 60 
mM Tris-HCl (pH 9), 15 mM (NH4)2SO4, 2 mM MgCl2, 200µM each of dATP, 
dCTP, dGTP, and dTTP, 0.5mM of each primer, and 2.5 units of Taq polymerase 
(Invitrogen).  The sequence of the primers used in this PCR were (OV mito F 
primer 5'-GTTTTAGGCTATTGGGCTG-3') and (OV mito R primer 5'-
ACATCAAAGGCAACATCCA-3'). The cycling conditions consisted of one cycle 
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of three minutes at 94°C.  This was followed by 45 cycles of 30 seconds at 94°C, 
30 seconds at 55°C, and 1 minute and 30 seconds at 72°C.  The PCR was 
completed with 10 minutes at 72°C and was held continuously at 4°C. 
Nested amplifications were performed in a total volume of 25 µl containing 
the same reaction components of the mitochondrial PCR with the exception of 
using 0.5mM of the first step amplification product from the mitochondrial PCR as 
a template.  The nested reaction targeted a 97nt fragment that was internal to the 
205nt fragment targeted in the first stage reaction.  The sequence of the primers 
used in the nested PCR were (OV mito F primer 5’-
CTATGTTGATTCGTTTTGAG-3’), OV mito R primer 5’-
AAAACACCATGCATAGTAAG-3’).  The cycling conditions consisted of one cycle 
of three minutes at 94°C, followed by 35 cycles of 45 seconds at 94°C, 30 
seconds at 55°C, and 1 minute and 30 seconds at 72°C.  The PCR was 
completed with 10 minutes at 72°C and was held continuously at 4°C. 
To analyze the O. volvulus DNA, gel electrophoresis was run using LE 
Quick Dissolve agarose mixed with 1X TAE (Tris base, acetic acid, EDTA)[1.5% 
gel, pH 7.8].  The samples are mixed with dye and loaded into the machine along 
with the 100 bp DNA ladder marker, positive, and negative controls.  The gel was 
run and then stained in an Ethium Bromide mixture for 30 minutes.  The gel was 
then read under a UV light. 
Protocol For Sequential Larvae Detection using Beads 
Limit of detection assays were then carried out using ten fold dilutions of 
O. volvulus DNA conducted with Streptavidin magnetic coated beads.  To the 
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dilutions of purified genomic DNA, the magnetic bead capture of DNA was 
performed as previously described.   
The O-150 and mitochondrial PCR assay were performed as previously 
described using the purified DNA.  An enzyme-linked immunosorbent assay then 
detected O-150 amplification products as previously described.  From the first 
stage OV mitochondrial PCR assay, a nested PCR assay and gel electrophoresis 
were run as previously described. 
Protocol For Larvae Detection 
Using L3 infected larvae, DNA extractions were performed by using one 
L3 aliquot in 100 µl PBS buffer and homogenizing using a microfuge pestle.  
DNA extractions were performed as previously described and the magnetic bead 
capture of DNA was performed. 
The O-150 and mitochondrial PCR assay were performed as previously 
described using the purified DNA.  An enzyme-linked immunosorbent assay then 
detected O-150 amplification products as previously described.  From the first 
stage OV mitochondrial PCR assay, a nested PCR assay and gel electrophoresis 
were run as previously described. 
Protocol For Mixing 
After confirming that the Onchocerca larvae could be detected, the larvae 
and flies were combined for a mixing experiment.  In a microfuge tube, 200 fly 
heads and one L3 larva, obtained from the preparation described previously, 
were homogenized.  DNA extractions were performed as previously described 
and the magnetic bead capture of DNA was performed.   
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The O-150 and mitochondrial PCR assay were performed as previously 
described using the purified DNA.  An enzyme-linked immunosorbent assay then 
detected O-150 amplification products as previously described.  From the firs 
stage mitochondrial PCR assay, a nested PCR assay and gel electrophoresis 
were run as previously described. 
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Chapter Three:  Results 
In order to investigate the confirmatory and nested PCR assay to detect 
Onchocerca volvulus in pools of vector black flies, limit of detection assays were 
initially carried out using ten fold dilutions of O. volvulus genomic DNA.   
O. volvulus DNA was first run with the initial O-150 enzyme-linked 
immunosorbent assay and cytB PCR.  PCR primers were developed to amplify 
the 205nt (nucleotide) fragment of the cytochrome B gene of O. volvulus and 
confirmatory PCRs were then conducted.  Nested PCRs were then performed 
targeting a 97nt fragment internal to the 205nt fragment targeted in the initial 
assay.  
Figure 1.2 shows	  serially diluted genomic DNA extracted from adult 
female parasites and amplification products detected by O-150 PCR ELISA.  The 
samples were considered positive if their optical density exceeded the mean plus 
three standard deviations of the negative controls.  The dashed line is the cutoff 
of at 0.0528.  All nine samples were considered positive and the genomic sample 
diluted to 10.0E-09 showed the sensitivity of the assay by detecting the DNA at 
such a microscopic level.  
The initial, confirmatory, and nested PCR’s were then conducted using the 
genomic DNA.  Incorporating the nesting step into the protocol increased the 
biochemical sensitivity of the assay, lowering the limit of detection.  Figure 1.2 
shows data collected from three amplifications of serially diluted genomic DNA.  
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Figure 1.2.  Sequential dilutions of genomic DNA extracted from adult female 
parasites. 
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Figure 1.2 shows data collected from three amplifications of serially diluted 
genomic DNA.  Panel B is the first stage PCR assay performed using the O150 
primers (5’-GATTYTTCCGRCGAANARCGC-3’) and (5’-B-
GCNRTRTAAATNTGNAAATTC-3’, where B=biotin).  Panel B detected strong 
bands in lanes one through six.  Panel C is the first stage cytB PCR assay 
performed using the mitochondrial primers (OV mito F primer 5'-
GTTTTAGGCTATTGGGCTG-3'), (OV mito R primer 5'-
ACATCAAAGGCAACATCCA-3').  Panel C detected strong bands in lanes one 
through four.  Panel D is the nested cytB PCR assay performed using the 
mitochondrial primers (OV mito F primer 5’-CTATGTTGATTCGTTTTGAG-3’), 
OV mito R primer 5’-AAAACACCATGCATAGTAAG-3’).  Panel D detected strong 
bands for all samples in lanes one through nine.  The serially diluted DNA run in 
the nested PCR assay thus expressed a biochemical limit of detection that was 
comparable to the O-150 ELISA that is the preliminary test to detect the 
presence of O. volvulus.  
A protocol was developed (as described in Materials and Methods) to 
perform limit of detection assays using ten fold dilutions of O. volvulus DNA 
purified with biotinylated primers targeting the O-150 and cytB template 
sequences and Streptavidin magnetic coated beads.  
Figure 1.3 shows serially diluted genomic DNA extracted from adult 
female parasites that was further purified with the primers and streptavidin 
coated magnetic beads and amplification products detected by O-150 PCR 
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ELISA.  The samples were again considered positive if their optical density 
exceeded the mean plus three standard deviations of the negative controls.  The 
dashed line is the cutoff of at 0.2522.  All nine samples in panel A were 
considered positive in this ELISA assay.   
 
 
 
Figure 1.3.  Sequential Dilutions of genomic DNA extracted from adult female 
parasites purified with streptavidin coated magnetic beads. 
 
From the first stage PCR assay, a nested PCR assay and gel 
electrophoresis were run as previously described.  Panel B shows a gel 
electrophoresis of serially diluted genomic DNA extracted from adult females with 
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streptavidin coated magnetic beads.  A nested PCR was performed using the 
mitochondrial primers (OV mito F primer 5’-CTATGTTGATTCGTTTTGAG-3’), 
OV mito R primer 5’-AAAACACCATGCATAGTAAG-3’) to detected amplification 
products at 97nt.  Strong bands ands were detected for all nine serially diluted 
samples.   
To further explore the sensitivity of the assay, DNA extractions were then 
performed using individual L3 infective larvae (materials and methods as 
previously described) and the magnetic bead capture of DNA was performed. 
 
 
Figure 1.4.  DNA extractions from third stage infective larva purified with 
streptavidin magnetic coated beads. 
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Figure 1.4 shows DNA extracted from 9 duplicate extractions and 
magnetic bead purifications from samples containing a single L3 infective larva 
and amplification products detected by O-150 PCR ELISA.  The samples were 
considered positive if their optical density exceeded the mean plus three 
standard deviations of the negative controls.  The dashed line is the cutoff of at 
0.0610.  Eight out of nine samples were found to be positive and detected the O-
150 amplicons from the ELISA. 
Panel B shows the gel electrophoresis of the nested assay conducted on 
DNA extracted from the parasites.  A nested PCR was performed using the 
mitochondrial primers (OV mito F primer 5’-CTATGTTGATTCGTTTTGAG-3’), 
OV mito R primer 5’-AAAACACCATGCATAGTAAG-3’) to detected amplification 
products at 97nt.  Strong DNA bands were detected from all PCR products at 
97nt displaying accurate and sensitive detection of the parasites.  
After accurate larvae detection was confirmed, the larvae and flies were 
combined for a mixing experiment to detect one infective parasite in a pool of 200 
black flies by using streptavidin coated magnetic beads to isolate Onchocerca 
volvulus DNA from homogenates mixed with pools of vector black flies.  DNA 
extractions were performed as previously described and the magnetic bead 
capture of DNA was performed.  Below is the enzyme-linked immunosorbent 
assay showing the detected O-150 amplification products. 
Figure 1.5 shows the results from five experimental pools prepared by 
spiking 200 black fly heads with a single L3 larva.  DNA was purified from the 
spiked pools using the magnetic capture method and assayed for the presence 
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of O. volvulus DNA using the O-150 PCR ELISA and the cytB nested PCR 
assays.   
 
 
Figure 1.5.  DNA extractions from five experimental pools prepared by spiking 
black fly heads with a single L3 larva. 
 
The samples were considered positive if their optical density exceeded the 
mean plus three standard deviations of the negative controls.  The dashed line is 
the cutoff of at 0.0599.  All five samples were considered to have positive signals 
and accurately detected one L3 larvae mixed with 200 black fly heads. 
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Panel B shows the gel electrophoresis of the ctyB nested assay from DNA 
extracted from O. volvulus parasites prepared with pools of black flies.  A nested 
PCR was performed using the mitochondrial primers (OV mito F primer 5’-
CTATGTTGATTCGTTTTGAG-3’), OV mito R primer 5’-
AAAACACCATGCATAGTAAG-3’) to detected amplification products at 97nt.  
Strong bands were detected in lanes one, two, four and five.  A weak band was 
detected in lane three.  All spiked pools were still found to be positive which 
suggests the capture assay performed consistently well. 
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Chapter Four:  Discussion 
A PCR assay was employed targeting a specific repeated sequence family 
encoded in the nuclear genome of O. Volvulus, the O-150 repeat, to screen for 
the presence of the parasite in the pool of vector black flies.  This assay is highly 
sensitive but we also needed to ensure high specificity from an independent 
confirmation assay to show the absence of transmission.  An independent PCR 
confirmation assay was conducted targeting the 205nt (nucleotide) cytochrome B 
gene of the O. volvulus mitochondrion genome.  Nested PCRs were then 
performed targeting the 97nt fragment internal to the 205nt fragment targeted in 
the initial assay.  The nested PCR was utilized to increase the biochemical 
sensitivity of the assay and thereby lowering the limit of detection.  The 
mitochondrial genome was targeted because they are maternally inherited and 
not subject to diversity in generating mechanisms associated with sexual re-
assortment.  It is also not subject to genetic recombination and is highly 
conserved. 
The magnetic bead capture method was used to isolate Onchocerca 
volvulus DNA from homogenates prepared from pools of vector black flies.  
Throughout this experiment, Streptavidin magnetic beads are used for magnetic 
purification of the captured oligonucleotide-DNA complexes.  Streptavidin 
magnetic beads bind easily to the desired target and when placed in a magnetic 
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field, the bound material is efficiently separated from the rest of the sample.  
These beads are used because they have a strong affinity for biotin and have a 
high and constant binding capacity.  An indirect capture method was used, where 
the ligand was allowed to bind to the target, prior to the addition of the beads. 
They are spherical and have a large surface area per volume that allows for 
maximum bondage.  A 1:1 ratio of 5 µl 0.5 µm 0150 probe (OVS-2-biotin, B-
5’AATCTCAAAAAACGGGTACATA-3’, where B=biotin) and 5 µl 0.5 µm OV 
mitochondrial 2353 probe (B-5’GTTTTAGGCTATTGGGCTG-3’) were used in 
this experiment. 
The results of this new method of using streptavidin magnetic coated 
beads to magnetically purify pathogen genomic DNA demonstrated successful 
detection of parasite prevalence.  This purification process that captures and 
immobilizes the DNA on a magnetic bead has proven to be very reliable and 
sensitive.  This experiment has improved efficiency of pool screening of vector 
flies because there has been an increase in the amount of black flies in a single 
pool.  The bead capture method of purifying O. volvulus DNA is freer of PCR 
inhibitors and this allows for the size of the increased fly pools.  The efficiency of 
this assay will help to document the elimination of the focal transmission of 
Onchocerca volvulus and because this assay is a modification of the silica 
adsorption assay, the equipment will be very similar to that already being used. 
The high specificity obtained throughout this experiment using the nested assay, 
which was internal to the fragment targeted in the first stage reaction, will be 
used to assist in the documentation of the absence of transmission of O. volvulus 
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in many different areas of the world.  This improvement of the conventional assay 
will be implemented in many countries that are affected by Onchocerciasis to 
determine if transmission has been interrupted and focal elimination of the 
parasite has been achieved. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	   33 
 
 
 
References Cited 
 
 
Centers for Disease Control and Prevention. (2 Nov. 2010). Onchocerciasis. 
Retrieved from http://www.cdc.gov/parasites/onchocerciasis/ 
Cook, J. (2001). Towards a vaccine for onchocerciasis. Trends in Parasitology, 
17(12), 555-558. 
Cupp EW, Mackenzie CD, Unnasch TR.  (2011).  Importance of ivermectin to 
human onchocerciasis: past, present, and the future.  Research and 
Reports in Tropical Medicine 2: 81-92. 
Dynal. (2010). The attraction is simply magnetisk.  Dynabeads Streptavidin 
products and applications. Retrieved from 
http://tools.invitrogen.com/content/sfs/brochures/Dynabeads_Streptavidin_
Products_and_Applications.pdf 
Gopal, H. (2012). Oligonucleotide based magnetic bead capture of Onchocerca 
volvulus DNA for PCR pool screening of vector black flies. PLOS 
Neglected Tropical Diseases, 6(6), 1-5. 
Keddie, E. (1998). The mitochondrial genome of onchocerca volvulus: sequence, 
structure and phylogenetic analysis. Molecular and Biochemical 
Parasitology, 95, 111-127. 
Lindblade KA, Arana B, Zea-Flores G, Rizzo N, Porter CH, et al. (2007) 
Elimination of Onchocerca volvulus transmission in the Santa Rosa focus 
	  	   34 
of Guatemala.  American Journal of Tropical Medicine and Hygiene 77: 
334-341. 
MacIver, A. (2012). Standard diagnostics and path collaborate to produce a 
point-of-care rapid test for the neglected tropical disease onchocerciasis. 
PATH Standard Diagnostics 
Meredith SEO, Lando G, Gbakima AA, Zimmerman PA, Unnasch TR (1991) 
Onchocerca volvulus: Application of the polymerase chain reaction to 
identification and strain differentiation of the parasite.  Experimental 
Parasitology 73: 335-344. 
Nutman, T. (2002). Future directions for vaccine-related onchocerciasis. Trends 
in Parasitology, 18(6), 237-239. 
OEPA (2008) Onchocerciasis Elimination Program for the Americas.  
http://www.oepa.net/index.html (Accessed July 2013). 
Prichard, R. (2012). A research agenda for helminth diseases of humans: 
Intervention for control and elimination. PLoS Neglected Tropical 
Diseases, 6(4), 1-14. 
Rodriguez-Perez, MA, Dominguez-Vasquez A, Unnasch TR, Hassan HK, et al. 
(2013). Interruption or Transmission of Onchocerca volvulus in the 
Southern Chipas Focus, Mexico.  PLOS Neglected Tropical Diseases, 
7(3), 1-9. 
Golden A, Steel C, Yokobe L, Jackson E, Barney R, Kubofcik J, Peck R, 
Unnasch TR, Nutman TB, de Los Santos T, Domingo GJ, 2013. Extended 
Result Reading Window in Lateral Flow Tests Detecting Exposure to 
	  	   35 
Onchocerca volvulus: A New Technology to Improve Epidemiological 
Surveillance Tools. PLOS One 8: e69231 
Udall DN.  (2007).  Recent Updates on Onchocerciasis: Diagnosis and 
Treatment.  Clinical Infectious Diseases 44: 53-60. 
Unnasch TR.  (1987).  DNA Probes to Identify Onchocerca volvulus.  Elsevier 
Publications, Cambridge 0169-4758/87 
Unnasch TR, Williams SA.  (2000).  The genomes of Onchocerca volvulus.  
International Journal for Parasitology 30, 543-552. 
Weil GJ, Steel C, Liftis F, et al.  (2000) A rapid-format antibody card test for 
diagnosis of onchocerciasis.  Journal of Infectious Disease 2000; 
182:1796-1799. 
World Health Organization (2012). Onchocerciasis (river blindness). World 
Health Organization. Retrieved from 
http://www.who.int/blindness/causes/priority/en/index3.html 
World Health Organization (2001) Criteria for certification of interruption of 
transmission/elimination of human onchocerciasis.  Geneva: World Health 
Organization.  WHO/CDC/CPE/CEE/2001.18a  
WHO/CDS/CPE/CEE/2001.18a  64p.
  
 
About the Author 
 
 Alexandra Jeanne Talsma was born in Winfield, Illinois and earned 
her Bachelor’s of Arts and Sciences in Biomedical Sciences at the University of 
South Florida.  She has also earned minors in Biomedical Physics and Public 
Health at the University of South Florida.  She is continuing her education by 
pursuing a Master’s of Science in Public Health at the same university in Global 
Communicable Diseases.  While finishing her degree, she has also earned a 
graduate certificate in infection control. 
 
  
 
  
 
 
 
 
